Why is Pfizer Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 1.09% and Operating profit at 5.85% over the last 5 years
2
Flat results in Sep 26
- NO KEY NEGATIVE TRIGGERS
3
Stock is technically in a Bearish range
- The technical trend has deteriorated from Mildly Bearish on 08-Sep-26 and has generated -10.76% returns since then
- Multiple factors for the stock are Bearish like MACD, Bollinger Band and KST
4
With ROE of 18.2, it has a Expensive valuation with a 4 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -23.29%, its profits have risen by 13.2% ; the PEG ratio of the company is 1.7
5
Below par performance in long term as well as near term
- Along with generating -23.29% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Pfizer for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Pfizer
-23.29%
-0.92
25.27%
Sensex
-2.0%
-0.13
14.98%
Quality key factors
Factor
Value
Sales Growth (5y)
1.09%
EBIT Growth (5y)
5.85%
EBIT to Interest (avg)
65.73
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.68
Sales to Capital Employed (avg)
0.67
Tax Ratio
25.93%
Dividend Payout Ratio
47.50%
Pledged Shares
0
Institutional Holding
19.15%
ROCE (avg)
52.20%
ROE (avg)
17.79%
Valuation Key Factors 
Factor
Value
P/E Ratio
22
Industry P/E
40
Price to Book Value
4.00
EV to EBIT
15.91
EV to EBITDA
14.97
EV to Capital Employed
10.31
EV to Sales
5.49
PEG Ratio
1.67
Dividend Yield
1.96%
ROCE (Latest)
64.80%
ROE (Latest)
18.19%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
Bullish
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
Mildly Bearish
Technical Movement
7What is working for the Company
CASH AND CASH EQUIVALENTS(HY)
Highest at Rs 3,169.88 cr
NET SALES(Q)
Highest at Rs 726.86 cr
PBDIT(Q)
Highest at Rs 261.20 cr.
PBT LESS OI(Q)
Highest at Rs 243.44 cr.
PAT(Q)
Highest at Rs 215.41 cr.
EPS(Q)
Highest at Rs 68.47
-2What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Pfizer
Net Sales - Quarterly
Highest at Rs 726.86 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 261.20 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 243.44 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 215.41 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 68.47
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Cash and Cash Equivalents - Half Yearly
Highest at Rs 3,169.88 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Here's what is not working for Pfizer
Non Operating Income - Quarterly
Highest at Rs 47.33 cr
in the last five quartersMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating Income